Dupilumab May Help Treat Lung Cancer, Reduce Tumors
Combining immunotherapy with dupilumab boosted lung cancer patients' immune systems, with one out of the six experiencing significant tumor reduction, according to findings published in Nature.
Category: Lung Cancer
Lung Cancer
Latest
Lung Cancer
Latest
Women Under 55 Now Diagnosed With Lung Cancer More Than Men
Reversing historical patterns, new research shows lung cancer rates in US women under 55 now surpass those in men.
Lung Cancer
Latest
Depression May Worsen Outcomes for Lung Cancer Patients
Lung cancer patients with moderate to severe depression are two to three times more likely to have inflammation levels that predict poor survival rates, a new The Ohio State University study found.
Imaging Agent Illuminates Lung Cancer Tumors
The FDA approves a new use of the imaging agent Cytalux to help light the way for surgeons during lung cancer surgery.
Read More
Racial Disparities in Lung Cancer Start With Research
Although it is well documented that Black smokers develop lung cancer at younger ages than white smokers even when they smoke fewer cigarettes, the guidelines that doctors use to recommend patients for screening have been slow to reflect the disparity.
Read More
FDA Approves AstraZeneca’s Lung Cancer Drugs
AstraZeneca said on Friday its lung cancer drugs Imfinzi and Imjudo have been approved by the U.S. Food and Drug Administration (FDA).
Read More
DNA Barcoding Reveals Cancer Cells’ Ability to Evade the Immune System
Some cancer cells can deploy parallel mechanisms to evade the immune system’s defenses as well as resist immunotherapy treatment, according to a new study from the Garvan Institute of Medical Research.
Read More
Lung Cancer: Biodesix Gets Federal Supply Contract for Diagnostic Tests
Biodesix offers healthcare providers and patients a comprehensive suite of diagnostic tests capable of supporting clinical decision-making across the lung cancer continuum.
Read More
FDA Votes Against Spectrum’s Lung Cancer Drug
Advisers to the FDA on Thursday voted against recommending Spectrum Pharmaceuticals’ experimental drug for the treatment of patients with a form of non-small cell lung cancer.
Read More
Patient Experiences in Lung Cancer Care
A recent study in Supportive Care in Cancer examined the findings of a cancer patient experience survey to identify possible patterns in patient-reported experiences of their lung cancer care.
Read More
Lung Cancer: Lumakras Cuts Risk by 34%
Amgen’s Lumakras pill reduced the risk of disease progression in patients with advanced lung cancer by 34% compared with chemotherapy in a clinical trial, the company said on Sunday.
Read More
NIH Telehealth Centers of Excellence to Study Cancer Care
The National Cancer Institute awarded $23M to establish telehealth centers of excellence on the role of telehealth in cancer-related care.
Read More
Sexual Dysfunction Common in Women with Lung Cancer
Sexual dysfunction is a common side effect among women with lung cancer, a new study finds.
Read More
On World Lung Cancer Day, A Push for Early Screenings
Each year on August 1st, the global respiratory community recognizes World Lung Cancer Day as a way to increase awareness and resources to fight the disease that accounts for 1-in-4 cancer deaths.
Read More
Lung Cancer: Lack of Mask Mandates Leaves Patients Feeling Unprotected
A lack of mask mandates at cancer centers has left patients feeling unsafe, according to reports from clinicians.
Read More